Main Article Content
Status epilepticus is a serious epileptic condition associated with significant morbidity and mortality. It can be divided into four stages: developing (seizures leading up to status epilepticus), established (>5 minutes convulsive status epilepticus, nonconvulsive/focal status epilepticus >10 min), refractory (failure of two adequately dosed antiseizure medications in different drug classes), and super-refractory (persisting despite >24 hours of anesthesia). All seizure types can develop to status epilepticus. Generalized convulsive status epilepticus has the largest potential for brain damage. The drug treatment algorithms for status epilepticus generally go through three stages, starting with benzodiazepines: lorazepam, midazolam, or diazepam as first line drugs, moving to levetiracetam, valproate or fos-phenytoin as second-line drugs, ending, if necessary, with anesthetics like propofol or midazolam. Lacosamide, topiramate, phenobarbital, brivaracetam, and perampanel are potential alternatives, and pentobarbital is commonly used when long-term anesthesia is needed. Super refractory status epilepticus is the form that usually causes the most concern. Treatment guidelines for newer treatment alternatives are often based only on case reports and small patient series. Such alternatives include ketamine, immunotherapy, ketogenic diet, inhalation anesthetics and hypothermia, and several surgical neurostimulation procedures. This chapter provides an overview of current treatment alternatives, with particular focus on refractory status epilepticus and super-refractory status epilepticus.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of individual chapters belongs to the respective authors. The authors grant unrestricted publishing and distribution rights to the publisher. The electronic versions of the chapters are published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Users are allowed to share and adapt the chapters for any non-commercial purposes as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source. The books in their entirety are subject to copyright by the publisher. The reproduction, modification, republication and display of the books in their entirety, in any form, by anyone, for commercial purposes are strictly prohibited without the written consent of the publisher.